Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuvaRing for Vaginal Microbiota and Bacterial Vaginosis
NCT02432404Phase 4Completed
- Sponsor
- University of Washington
- Start
- Mar 2016
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of etonogestrel + ethinyl estradiol in bacterial vaginosis (BV), sponsored by University of Washington. Started Mar 2016; status: completed.
02
Drugs
etonogestrel + ethinyl estradiol
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02432404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432404.